.png)
Addiction Treatment Services
Virtual Adolescent CD IOP
An Adolescent Chemical Dependency Intensive Outpatient Program (CD IOP) is designed specifically for teens struggling with substance use challenges. It provides structured, evidence-based treatment in a supportive and accessible virtual setting. Participants receive individualized care, group therapy, education, and recovery-focused support while maintaining their daily responsibilities at home and school. Treatment also focuses on improving decision-making, strengthening communication and relationships, and helping adolescents develop a supportive recovery environment.
The goal of the Adolescent CD IOP is to help young people discontinue substance use, understand the impact of drugs and alcohol on their lives, develop the skills needed to maintain recovery, and build a healthier and more stable future. Family participation and support are encouraged as important components of an adolescent’s recovery and long-term success. By offering services virtually, we are helping remove barriers to treatment and expanding access to care for adolescents and families throughout the state.
Wrap-around services offered to Intensive Outpatient Program participates include:
-
Medication Assisted Treatment
-
Case Management services
Medication Assisted Treatment
Medication-assisted treatment (MAT) is the use of medications, in combination with counseling and behavioral therapies, to treat substance use disorders. Medications used in MAT programs are FDA approved and known to be a highly affective first-line treatment options.
Medications we use within our MAT program:
-
Suboxone - buprenorphine/naloxone tablets
-
Sublocade - buprenorphine; monthly injection
-
Subutex - buprenorphine sublingual tablets
-
Vivitrol - naltrexone; monthly injection
-
ReVia or Depade - naltrexone tablets
-
Lucemyra - lofexidine tablets
MAT medications work by blocking the euphoric effects of alcohol and opioids, relieving physiological cravings, and normalizing brain chemistry.
The benefits of MAT over other types of treatment have been well demonstrated. Over 500 peer-reviewed research studies have shown that MAT reduces cravings, reduces illicit opioid and alcohol use, provides relief from opioid withdrawal symptoms, and significantly decreases relapse rates.
Other benefits of Medication-assisted Treatment:
-
Improved patient survival - recent studies have found that the use of MAT medications, combined with regular therapy, reduces the death rate among those living with chemical dependency by 50% or more.
-
Decreased alcohol and opiate use - studied have found in patients who are prescribed MAT medications for opiate and/or alcohol use disorder, 90% maintain sobriety at the 2-year mark.
-
Relief from debilitating withdrawal symptoms - buprenorphine tricks the brain by interacting with the same receptors that heroin works on. In this way, Suboxone eliminates the harsh withdrawal effects that occur at the beginning of detox.
-
Curbing or eliminating opiate and/or alcohol cravings - vivitrol and buprenorphine both work by tricking the same receptors opiates and alcohol interact with into believing they are still taking in opiates or alcohol. This process eliminates cravings because the receptors do not crave what they believe they still have.